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Abstract 
 
Membrane proteins account for a third of the eukaryotic proteome, but are greatly under-
represented in the Protein Data Bank. Unfortunately, recent technological advances in X-ray 
crystallography and electron microscopy cannot account for the poor solubility and stability of 
membrane protein samples. A limitation of conventional detergent-based methods is that detergent 
molecules destabilize membrane proteins, leading to their aggregation. The use of orthologues, 
mutants and fusion tags has helped improve protein stability, but at the expense of not working with 
the sequence of interest. Novel detergents such as GNG, MNG and calixarene-based detergents can 
improve protein stability without compromising their solubilising properties. SMALPs focus on 
retaining the native lipid bilayer of a membrane protein during purification and biophysical analysis. 
Overcoming bottlenecks in the membrane protein structural biology pipeline, primarily by 
maintaining protein stability, will facilitate the elucidation of many more membrane protein 
structures in the near future. 
 
 
Introduction  
Membrane proteins – why are they important? 
Membranes are a vital component of any cell creating a barrier between the intracellular 
components of the cell and its extracellular environment. This barrier allows the cell to regulate 
what enters and exits through membrane proteins. Not only are membrane proteins localised in the 
cell surface membranes but also internal membranes of organelles such as mitochondria, 
endoplasmic reticulum, golgi and nuclei [1]. Membrane proteins make up between 20 and 30% of all 
proteins in eukaryotic cells [2] and have a wide range of functions as exhibited by transporters (e.g. 
ABCs), enzymes, receptors (e.g. GPCRs) and anchoring proteins. Because of the importance of these 
functions, when mutations occcur they can cause severe disease states such as cystic fibrosis, 
neurodegenerative diseases, cancers, cardiovascular diseases and immunological disorders [3-5]. 
 
Membrane proteins – what are the difficulties? 
Expression 
One bottleneck in membrane protein structural biology pipelines is the low abundance of the 
membrane protein of interest. Membrane proteins are naturally expressed at low levels (with some 
exceptions such as rhodopsin, which is very abundant in the retina) [6], so the separation of 
endogenous membrane proteins from biological sources in sufficient quantity represents a real 
limitation.  Overexpression of membrane proteins increases the yield per cell and has the advantage 
of creating recombinant membrane proteins, which can incorporate tags to aid purification and 
stability. Escherichia coli is a commonly-used host for prokaryotic membrane protein production 
whereas eukaryotic membrane proteins often need a eukaryotic host such as mammalian cells, yeast 
or insect cells  [7, 8]. Membrane proteins can sometimes be toxic to the cells used for their 
expression. The use of inducible expression systems and some specific inhibitors and/or cell-free 
expression can represent a solution to this toxicity. Correct folding and post translational 
modifications are key for obtaining functional proteins [9]. Notably, compared to proteins expressed 
in the cytosol or secreted into the growth medium, there is limited space in the plasma membrane 
when over-expressing membrane proteins, which therefore limits the maximum theoretical yield. 
 
Extraction/solubilisation & purification 
Membrane proteins must be extracted/solubilised from the membrane before being purified. 
Solubilising a membrane protein whilst maintaining its stability is an enduring challenge in 
membrane protein structural biology. The conventional and most commonly-used method for 
solubilising membrane proteins is the addition of surfactants, known as detergents. These 
amphipathic molecules are able to replace the lipid bilayer by forming micelles (Figure 1A) that allow 
the membrane protein to become soluble in aqueous solutions [10, 11]. Unfortunately many 
detergents do not maintain the structure and function of membrane proteins, which can become 
misfolded once extracted from their native lipid environment, possibly due to the lack of lateral 
pressure. Since detergents have varying characteristics, it is hard to predict which detergent will be 
optimal for a particular membrane protein; the conditions for efficient yet functional extraction are 
also protein dependent. The mechanism behind this is poorly understood, nevertheless some 
general rules exist such as short chain detergents are not as effective for solubilisation, but are 
better for crystallization than long chain detergents, which may interfere with protein-protein 
interactions within a packed crystal [11]. Some detergents needed for solubilisation and stabilisation 
of membrane proteins can interfere with affinity purification. Therefore detergent exchange prior to 
purification may be necessary. Although detergents solubilise and allow membrane protein 
purification, it is a real challenge to avoid aggregation and maintain structural and functional 
integrity. Therefore, detergent screening requires functional and structural cross-validation.  
Proteoliposomes (Figure 1B) and membrane scaffold proteins  (MSP) (Figure 1C) are two model 
systems in which a membrane protein can be reconstituted back into a lipid bilayer allowing protein 
function to be examined. For example, the reconstitution of membrane protein transporters into 
proteoliposomes allows their transport function to be investigated [12]. However, the orientation of 
the protein cannot be controlled, which can be limiting for some assays and to antibody discovery 
screening. MSP are capable of self-assembling into discoidal nanoparticles that encapsulate the 
membrane protein giving it a native-like lipid environment that promotes stability and solubility [13]. 
Although both approaches allow the membrane protein to be in a lipidic environment, and have 
allowed many functional and mechanistic details to be examined, they still require initial detergent 
solubilisation and purification prior to reconstitution. 
 
Structural biology of membrane proteins 
X-ray crystallography 
X-ray crystallography has been the single most successful technique in determining high resolution 
structures of membrane proteins.  However, the rate of success is not increasing as quickly as 
initially expected in comparison to that of soluble proteins. Producing 3D protein crystals for X-ray 
crystallography requires a membrane protein that is highly pure, stable and homogenous.  The 
optimal detergents used to solubilise and stabilise a membrane protein are not necessarily the same 
as the best detergents for 3D crystal formation, so detergent exchange and optimisation are 
necessary. Detergents may also interfere with protein-protein contacts in a crystal with short chain 
detergents therefore being more suitable for crystallisation [11]. One method that has been used to 
circumvent some of the problems of using detergents in crystallography is the use of “in cubo” 
systems that use lipid structures [9] such as the lipidic cubic phase (LCP). The idea behind these 
systems is that the membrane protein is surrounded by an environment that is close to the 
constituents of its natural lipid bilayer. The membrane protein should therefore have a more natural 
and stable conformation and is more likely to produce protein crystals. Other approaches that 
promote stability during crystallisation trials are to use a truncated and/or mutated version of the 
protein [14]. However, this may require a significant deviation from the native protein sequence that 
may be limiting to understanding the mechanism of action and to drug development. 
 
 
Electron microscopy 
Until recently the use of electron microscopy (EM) as a structural technique for membrane proteins 
has been limited by low resolution. Recent technical advances in microscopes, classification methods 
to sort particles, direct-detection cameras and the stabilisation of membrane proteins has led to 
improvements in resolution [15-17]. Single particle EM can determine the structure of a membrane 
protein by imaging individual particles. The membrane protein particles can be prepared either by 
negative stain or freezing in vitreous ice (cryo-EM) [16]. There is less artefactual information 
produced from cryo-EM, but negative staining has the advantage of maintaining highly-stable 
sample specimens that are less sensitive to radiation and have much better contrast [16]. Images of 
membrane proteins by single particle EM can be enhanced by averaging particles within the same 
class [18]. These electron micrographs can be used to pick particles, obtain class averages and back 
project them into a 3D density map of the membrane protein using imaging process software such 
as SPIDER, EMAN or IMAGIC [15]. Another method called electron crystallography consists of 
producing thin layers of planar, two-dimensional (2D) crystals of membrane proteins which are able 
to scatter electrons [19]. Electron crystallography can therefore generate structures in a near-to-
native environmental state [20]. Notably, these approaches still require high quality crystals, which is 
not the case for single particle EM. EM can also provide information about different structural 
states, conformations or oligomers of the protein within a single sample, thanks to classification 
routines [15]. This is only possible in X-ray crystallography if different structures can be solved.  
 
NMR 
Nuclear magnetic resonance (NMR) has produced over 100 membrane protein structures. This has 
been done mostly through the use of solution-state NMR, but oriented solid-state and magic-angle 
spinning solid-state NMR are starting to make an increasing contribution [21-23] . Structures of beta-
barrel, alpha-helical and membrane-associated proteins have all been solved by NMR. However, 
most membrane proteins are too large for NMR structural studies: the majority of known structures 
solved by NMR are of proteins with molecular masses below 20 kDa. Notably, the 34 kDa CXCR1 
chemokine G protein-coupled receptor (GPCR) structure was elucidated by rotationally aligned (RA) 
solid-state NMR [21].  NMR also has an important role to play in investigating protein-protein, and 
ligand- protein interactions as well as for fragment-based drug discovery [24-26]. 
 
 
 
 
Overcoming problems with stability 
Despite technical improvements in the expression (and purification) of membrane proteins and with 
structural methods, a major challenge remaining in membrane protein structural biology is the 
instability of protein samples. 
Conventional methods of stabilising membrane proteins are the use of orthologues, ligand binding, 
mutagenesis and protein engineering, which each come with their own set of problems. Although 
the use of orthologues means the target sequence of interest will not be studied, an orthologue may 
be more readily expressed and determination of its structure can be used to generate a molecular 
model of the target protein, as illustrated by the case of using Sav 1866 to model human MRP4 [27]. 
The ability of ligands to stabilize membrane proteins can help reduce flexibility and therefore 
facilitate structure determination, aswell as provide details on specific ligand/protein interactions, 
however it does often provide only a single snapshot of a highly dynamic process. The binding of 
antibodies or nanobodies has also been used as a way to stabilise membrane proteins [6]. 
Mutagenesis and protein engineering can produce more stable membrane proteins by alanine 
scanning [14, 28] .  Fusion proteins improve crystallisation by swapping unstable areas with T4 
lysozyme, an approach which has been successful with GPCRs such as the adenosine A2a receptor 
[29].  
 
Novel extraction/solubilisation approaches 
Although the use of mutants and fusion proteins has been very successful, there is always the risk 
that they differ from the native structure.  One approach to improve stability of wild-type proteins is 
to develop new methods for extraction and solubilisation which provide greater stability to the 
protein. 
Glucose neopentyl glycol and maltose neopentyl glycol  
Glucose neopentyl glycol (GNG) (Figure 2A) and maltose neopentyl glycol (MNG) (Figure 2B) are two 
classes of amphiphiles that are structurally similar, with the hydrophilic groups of GNG derived from 
glucose and MNG derived from maltose. The difference between these detergents and more 
conventional detergents with similar structures, such as n-dodecyl β-D-maltoside 
DDM (Figure 2C) is the central quaternary carbon atom that is derived from neopentyl glycol 
allowing for the addition of two hydrophobic and hydrophilic groups [30]. GNG has four different 
variants and MNG has three with the difference involving the attachment of the hydrophobic chain 
to the quaternary carbon [31]. Use of GNG-3 has help to produce the structure of Na+ -pumping 
pyrophosphatase [32] and human aquaporin 2 (AQZ 2) [33]. MNG-3 has demonstrated great 
solubility and stability characteristics and its use facilitated the determination of the high resolution 
structure of more than 10 GPCRs [34]. Although it should be noted that for many of these structures, 
mutational/fusion protein approaches were also used in conjunction with the novel detergents. 
Calixarenes 
Another novel class of detergents is based on the calixarene platform. These detergents have the 
same general structure as conventional detergents (polar head group and hydrocarbon chain) but 
also contain a calixarene platform of aromatic rings as shown in Figure 2D. They are capable of 
making specific contacts with a membrane protein to enable them to solubilise and stabilise at the 
same time. Specific interactions between the hydrophobic tail and the transmembrane domains of 
membrane proteins allow competition with lipids to facilitate solubilisation. In addition, interactions 
between the calixarene platform, carboxylate or sulfonate groups with aromatic and charged amino 
acid residues (corresponding to π stacking and salt bridge interactions) help to stabilise the protein. 
The use of these detergents was shown to maintain structure and function of transporter proteins 
[35] and helped maintain interactions between BAG3 and its corresponding partner at the 
membrane of macrophages. This allowed the identification of IFITM2 as a specific partner and 
provided molecular clues to signalling in the context of pancreatic cancer [36]. Some calixarenes 
have been shown to facilitate crystallisation of proteins [35, 37, 38].  Significant progress has been 
made in generating different calixarenes with different chemical characteristics to favour 
solubilisation and stabilisation at the same time, to improve stability after solubilisation or to 
facilitate crystallisation.  
SMALPs 
Styrene maleic acid (SMA) is a co-polymer made up of alternating units of styrene and maleic acid. 
This copolymer has the ability to solubilise lipid membranes into nanodisc-like structures termed 
SMA lipid particles (SMALPs; also known as native nanodiscs or lipodisqs), where a small disc of lipid 
bilayer is encircled by the SMA co-polymer [39-41]. During the formation of SMALPs from a 
biological membrane, membrane proteins can become trapped inside these discs (as shown in 
Figure 1D), solubilising them into small particles  (much like nanodiscs when using membrane 
scaffolding proteins), but without the need for detergent at any stage. The proteins within a SMALP 
can be effectively purfied using affinity chromatography [39, 42-44]. The particles are stable once 
formed so there is no need to supplement buffers during purification as there is when using 
detergents; this is a major cost advantage. The membrane protein that is encompassed inside the 
SMALP is now stable in its native lipid environment, allowing access to both sides of the membrane 
protein and aiding in functional and structural studies. Proteins within SMALPs have been shown to 
bind ligands comparably to those in the native membrane [44]. The use of SMALPs has facilitated 
improved thermostability and homogeneity of membrane proteins such as P-glycoprotein (P-gp) and 
the adenosine A2a receptor [39, 42, 44]. To date no crystal structure has been reported using 
SMALPs but both negative stain and cryo-EM  low resolution structural maps have been determined 
[39, 43]. Unlike MSP-nanodiscs, the polymer does not show significant extra-electron density; EM 
shows a very small annulus of lipids and polymer. 
 
Conclusion & perspectives 
Membrane protein structural biology is challenging. Not only must the membrane protein be 
expressed at high enough levels for structural studies, it must also have the correct conformation, 
homogeneity and stability. Regardless of the structural biology method used, the supply of stable, 
purified protein is still a major bottleneck, which is now being addressed with a range of novel 
approaches (Table 1). One of the biggest challenges is caused by the need to solubilise membrane 
proteins. The most common method of solubilising membrane proteins is with detergents. Although 
conventional detergents such as DDM are capable of making membrane proteins soluble in aqueous 
solution, and much has been achieved using them, they often do not stabilise the membrane protein 
efficiently and can lead to protein aggregation [11]. To overcome these problems, novel detergents 
such as GNG, MNG and calixarenes have been produced that enhance stability [30, 34, 35].  Whilst 
the number of structures obtained using these novel detergents is still much lower than with 
conventional detergents, this may just be a matter of time. There are reports in the literature of 
previously challenging proteins that are now able to be extracted and purified to the degree needed 
for structural studies using these new molecules [45-47]. It is interesting to note that both the 
GNG/MNGs and Calixarenes contain larger, more structured head groups than conventional 
detergents, and this may be a key factor in their stabilising properties. In fact a recently published 
study using an even larger branched pentameric sugar based headgroup reports even greater 
stabilising properties, but this has not yet been used for structural studies [48]. 
An alternative approach is to use SMA co-polymer to solubilise and purify membrane proteins whilst 
retaining the lipid bilayer environment [39]. This approach has proved successful to date for all cell 
types tested, and a range of different membrane proteins.  One limitation of this approach is that 
the size of discs formed with SMA are limited to approximately 10nm diameter, thus it is not suitable 
for large membrane complexes. The number of lipids within a SMALP will depend upon the size of 
the membrane protein encapsulated, and this may also influence the fluidity of the bilayer. For 
example it has been shown that in a lipid only SMALP, the central lipids behave much like a native 
bilayer, whilst the lipids at the edges are much more ordered [41]. Another limitation of SMALPs is 
their sensitivity to divalent cations such as magnesium which is an important co-factor for some 
biological reactions. Whilst a crystal structure from SMA purified protein has not yet been achieved, 
the increased stability, homogeneity and ease of concentration are all promising factors, and the 
sensitivity to magnesium may provide a way to remove the SMA to aid crystallization and/or 
reconstitution.  SMALPs have however been shown to be suitable for single particle EM studies, and 
with the excellent advances made recently with enhanced microscopes and classification methods to 
sort particles,  increasing the resolution that can be obtained by EM  to almost atomic resolution 
[15-17], this has enormous potential for the future. 
 
 
 
 
 
 
  
Table 1: A table outlining limitations and current solutions throughout the membrane protein 
structural biology pipeline. 
Process Limitation Solution 
Expression 1. Naturally low in abundance
2. Overexpression can lead to 
misfolded and non-functional 
membrane proteins 
1. Over-expression of membrane 
protein 
2. Find the best expression host and 
optimise expression conditions that 
allow high-yielding, functional 
expression 
Solubilisation and 
stabilisation 
1. Loss of native lipid membrane 
reduces lateral pressure and causes 
protein to collapse 
2. Detergent solubilisation denatures 
proteins  
1. SMA and MSP can encapsulate 
membrane proteins in their native 
lipid enviroment 
2. Screen the best detergent that 
allows solubilisation and 
stabilisation, by considering new 
detergents such as GNG, MNG and 
calixarenes  
Purification 1. Some detergents interfere with 
binding 
2. Samples must be homogeneous and 
in high concentration for functional 
and structural studies 
1. Exchange detergents at different 
steps (solubilisation and 
purification) or use SMA which 
allows a detergent-free purification 
whilst maintaining stability 
2. Fine-tune solubilisation, stabilisation 
and affinity purification conditions 
to avoid aggregates (observed in 
size exclusion chromatography or 
native PAGE) and maintain 
functionality 
Functional and 
Structural Studies 
1. Detergents can interfere with 
functional study  
2. No one detergent can solubilise, 
stablise and be used for 
crystallography 
3. Producing 3D crystals requires 
highly stable and homogenous 
samples 
1. Cross validate the solubilisation and 
purification trials with functional 
studies and if necessary reconstitute 
the protein in proteoliposomes or 
nanodiscs 
2. GNG, MNG and calixarenes can be 
used to solubilise and stabilise at the 
same time, improve stability and 
facilitate crystallisation 
3. EM can handle some degree of 
heterogeneity but requires high 
purity 
 
 
  
Figure legends 
Figure 1: Cartoons of detergent micelles, proteoliposomes, membrane scaffold proteins (MSP) and 
SMA lipid particles (SMALPS). These cartoons show how the phospholipids (red circles, black zig-
zags) or detergents (orange circles, black zig-zags) interact with the blue membrane proteins. The 
orange barrels of the membrane scaffold protein represent apolipoprotein A1 (used in MSP) and the 
green disc in the SMALP cartoon represents SMA. 
 
Figure 2: Chemical structures of DDM, MNG, GNG and calixarene-based detergents. There are 
similarities in the structures of DDM, MNG and GNG. However, MNG and GNG have maltose and 
glucose head groups attached to a central quaternary carbon atom that is derived from neopentyl 
glycol allowing for the addition of two hydrophobic hydrocarbon chains. One calixar-based 
detergent, so-called calix[4]arene is made of 4 aromatic rings with three hydrophilic sodium 
carboxylate groups at the para position of the calixarene platform. The hydrophobic part consists of 
one aliphatic tail (which can be any length, here decyl) grafted onto one of the phenolic groups.  
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